Revisions and debates over a draft of stage 2 meaningful use requirements continue on with a focus on how much to increase thresholds from stage 1, according to an InformationWeek news report.
Paul Tang, MD, of the HIT Policy Committee and chair of the Meaningful Use Workgroup, said although thresholds will generally increase from stage 1 through stage 2 to stage 3, the committee will have two more meetings to review the measures. Committee members have already expressed concern over the threshold increases and whether the increases will be arbitrary.
In reference to Dr. Tang’s proposal that computerized physician order entries be expanded from 30 percent of just medication orders in stage 1 to 60 percent of all medication lab and radiology orders, CIO of Intermountain Healthcare Marc Probst said, "We don’t have any history, and we haven’t gathered a lot of detail about what’s been brought in [from stage 1] and the success rates, so I don’t know if going from 30 percent to 60 percent is a high mountain or an average mountain."
Several committee members, including Mr. Probst and senior consulting architect of Kindred Healthcare Larry Wolf, have also advocated pushing back the start of stage 2 meaningful use to 2014 to give the healthcare industry time to set requirements and implement changes.
Read the news report about stage 2 meaningful use.
Read other coverage about meaningful use:
- Survey Indicates Top Five Reasons Providers Aren’t Ready for Meaningful Use
- CHIME: 50% Drop in Number of CIOs Confident in Meeting Meaningful Use
Paul Tang, MD, of the HIT Policy Committee and chair of the Meaningful Use Workgroup, said although thresholds will generally increase from stage 1 through stage 2 to stage 3, the committee will have two more meetings to review the measures. Committee members have already expressed concern over the threshold increases and whether the increases will be arbitrary.
In reference to Dr. Tang’s proposal that computerized physician order entries be expanded from 30 percent of just medication orders in stage 1 to 60 percent of all medication lab and radiology orders, CIO of Intermountain Healthcare Marc Probst said, "We don’t have any history, and we haven’t gathered a lot of detail about what’s been brought in [from stage 1] and the success rates, so I don’t know if going from 30 percent to 60 percent is a high mountain or an average mountain."
Several committee members, including Mr. Probst and senior consulting architect of Kindred Healthcare Larry Wolf, have also advocated pushing back the start of stage 2 meaningful use to 2014 to give the healthcare industry time to set requirements and implement changes.
Read the news report about stage 2 meaningful use.
Read other coverage about meaningful use:
- Survey Indicates Top Five Reasons Providers Aren’t Ready for Meaningful Use
- CHIME: 50% Drop in Number of CIOs Confident in Meeting Meaningful Use